← Back to headlines
Roche and Nurix Strike $2.3 Billion Blood Cancer Drug Deal
Pharmaceutical companies Roche and Nurix Therapeutics have announced a collaboration and licensing agreement worth up to $2.3 billion to develop and commercialize new treatments for blood cancer.
8 Jun, 13:17 — 8 Jun, 13:17
Sources
Showing 1 of 1 sources
